Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Blood Advances|October 22, 2020
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and responseOk-Kyong Chaekal, Andromachi Scaradavou, Emeline Masson Frenet, et al.
Developmental Cell|December 26, 2015
A Negative Regulatory Mechanism Involving 14-3-3ζ Limits Signaling Downstream of ROCK to Regulate Tissue Stiffness in Epidermal HomeostasisJasreen Kular, Kaitlin G Scheer, Natasha T Pyne, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 25, 2022
ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex VivoAndrew M K Law, Jiamin Chen, Yolanda Colino-Sanguino, et al.
Nature Communications|July 26, 2018
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancerAurélie S Cazet, Mun N Hui, Benjamin L Elsworth, et al.
Cell Reports|September 15, 2021
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imagingAlessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.
Cell Reports|October 6, 2017
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease ContextsMax Nobis, David Herrmann, Sean C Warren, et al.
Science Advances|September 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusKendelle J Murphy, Daniel A Reed, Claire Vennin, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 5